These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 7684660

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine.
    de Paulis A, Ciccarelli A, de Crescenzo G, Cirillo R, Patella V, Marone G.
    J Allergy Clin Immunol; 1996 Jul; 98(1):152-64. PubMed ID: 8765829
    [Abstract] [Full Text] [Related]

  • 45. Basophils from patients with allergic asthma show a primed phenotype.
    Lie WJ, Knol EF, Mul FP, Jansen HM, Roos D, van der Zee JS.
    J Allergy Clin Immunol; 1999 Nov; 104(5):1000-7. PubMed ID: 10550745
    [Abstract] [Full Text] [Related]

  • 46. The effect of terfenadine on the immediate and late-phase reactions mediated by immunoglobulin E.
    de Weck AL, Derer T, Bischoff SC, Takafuji S.
    Int Arch Allergy Immunol; 1993 Nov; 101(3):326-32. PubMed ID: 7686799
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. IL-3-induced histamine release from human basophils. Dissociation from cationic dye binding and down-regulation by Na+ and K+.
    Tedeschi A, Palella M, Milazzo N, Lorini M, Miadonna A.
    J Immunol; 1995 Sep 01; 155(5):2652-60. PubMed ID: 7544380
    [Abstract] [Full Text] [Related]

  • 49. Influence of bronchial allergen challenge on histamine release by human basophils.
    Lie WJ, Van Der Veen MJ, Knol EF, Mul FP, Jansen HM, Roos D, Van Der Zee JS.
    Clin Exp Allergy; 2000 Jun 01; 30(6):882-90. PubMed ID: 10848908
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a.
    Bischoff SC, de Weck AL, Dahinden CA.
    Proc Natl Acad Sci U S A; 1990 Sep 01; 87(17):6813-7. PubMed ID: 1697689
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Comparative effects of basophil-directed growth factors.
    Yoshimura-Uchiyama C, Yamaguchi M, Nagase H, Fujisawa T, Ra C, Matsushima K, Iwata T, Igarashi T, Yamamoto K, Hirai K.
    Biochem Biophys Res Commun; 2003 Mar 07; 302(2):201-6. PubMed ID: 12604332
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Effect of TYB-2285 on histamine release from human basophils in the presence/absence of IL-3.
    Tominaga T, Watanabe A, Hayashi H, Yanagihara Y, Koda A.
    Gen Pharmacol; 1993 Mar 07; 24(2):345-8. PubMed ID: 7683300
    [Abstract] [Full Text] [Related]

  • 58. Peptide analogues of consensus receptor sequence inhibit the action of cytokines on human basophils.
    Bischoff SC, de Weck AL, Dahinden CA.
    Lymphokine Cytokine Res; 1992 Feb 07; 11(1):33-7. PubMed ID: 1533539
    [Abstract] [Full Text] [Related]

  • 59. Late IL-3-induced phenotypic and functional alterations in human basophils require continuous IL-3 receptor signaling.
    Kämpfer SS, Odermatt A, Dahinden CA, Fux M.
    J Leukoc Biol; 2017 Jan 07; 101(1):227-238. PubMed ID: 27443880
    [Abstract] [Full Text] [Related]

  • 60. Recombinant histamine-releasing factor enhances IgE-dependent IL-4 and IL-13 secretion by human basophils.
    Schroeder JT, Lichtenstein LM, MacDonald SM.
    J Immunol; 1997 Jul 01; 159(1):447-52. PubMed ID: 9200485
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.